Clik here to view.
BIO Statement on Recent Developments in Japan’s Pharmaceutical Reimbursement...
WASHINGTON Joseph Damond, Senior Vice President for International Affairs at the Biotechnology Innovation Organization (BIO), released the following statement in response to recent developments in...
View ArticleClik here to view.
日本の薬価・保険収載制度における最近の動向に対するBIOの声明
ワシントン （ビジネスワイヤ） — バイオテクノロジーイノベーション協会（BIO）国際業務担当シニアバイスプレジデントのジョセフ・デーモンドは、日本の薬価・保険収載制度における最近の動向に対し、以下の声明を発表しました。...
View ArticleClik here to view.
NTT DATA Services Announces Partnership with AnatomyWorks for Brain Mapping...
CHICAGO NTT DATA Services, formerly Dell Services, today announced its partnership with AnatomyWorks to further enhance analytics tools that will provide greater brain mapping detail and proficiency...
View ArticleClik here to view.
NINLARO™ (ixazomib) Receives Conditional Approval from the European...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission has granted conditional marketing authorization for NINLAROTM...
View ArticleClik here to view.
NTT DATA Services Announces Partnership with Imbio for Lung Analytic...
CHICAGO NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance...
View ArticleClik here to view.
COA 2016 in Beijing, China: joimax® Shows Major Presence and Inaugurates New...
IRVINE, Calif. joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic...
View ArticleClik here to view.
Innovus Pharma Signs $2 Million a Year Exclusive License and Distribution...
SAN DIEGO Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and...
View ArticleClik here to view.
MinInvasive Announces a New Round of Financing and Strategic Partnership with...
MAGAL, Israel MinInvasive Ltd. developer of the OmniCuff™ device for the treatment of rotator cuff repair, announced today the completion of a financing transaction and a strategic partnership with...
View ArticleClik here to view.
Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing...
KONSTANZ, Germany & OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant...
View ArticleClik here to view.
武田薬品: ドイツにおけるデング熱ワクチン製造設備建設に対する投資について
独コンスタンツ & 大阪 （ビジネスワイヤ） — 当社は、このたび、ドイツ・ジンゲンの製造拠点において、1億ユーロ以上を投資し、新たにデング熱ワクチンの製造設備を建設することとなりましたので、お知らせします。本設備投資は、デング熱の予防における重要なアンメットニーズを満たすための当社の取り組みの大きな一歩となります。...
View ArticleClik here to view.
Sosei Subsidiaries Heptares to Acquire G7 Therapeutics to Extend Leadership...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, has signed a share purchase...
View ArticleClik here to view.
FDA Accepts for Review a Supplemental New Drug Application to Expand Labeling...
TOKYO, Japan & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck today announced the U.S. Food and Drug Administration (FDA) has determined that the supplemental New Drug...
View ArticleClik here to view.
Clik here to view.
biosurfit、医師による糖尿病の診断とモニタリングを支援するspinit® HbA1cポイントオブケア血液検査法のCEマークを取得
ポルトガル・リスボン （ビジネスワイヤ） — インビトロ・ポイントオブケア（PoC）診断技術企業のbiosurfit SA（以下、biosurfit）は本日、当社のHbA1c （ヘモグロビンA1c）検査法がCEマーク（Conformité Européenne）を取得したと発表しました。本検査法は、spinit®ポイントオブケア装置で利用可能な一連の検査法の3番目のものです。...
View ArticleClik here to view.
Minomic Announces Completion of Oversubscribed Capital Raising at AGM
SYDNEY Immuno-oncology company, Minomic International Ltd, announced the successful completion of its current funding round at its Annual General Meeting of Shareholders on Tuesday November 29. The...
View ArticleClik here to view.
Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with...
LONDON & BRISBANE, Calif. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved...
View ArticleClik here to view.
武田薬品とLightstone社によるCerevance社の設立について
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 武田薬品工業株式会社（本社：大阪市中央区、以下「武田薬品」）とLightstone...
View ArticleClik here to view.
Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TOKYO:4502): This Smart News Release features multimedia. View the full release here:...
View ArticleClik here to view.
GVK BIO宣布启用一家符合GMP规范的分析服务实验室
印度海得拉巴 (美国商业资讯) — 亚洲领先的生命科学服务组织之一GVK Biosciences今天宣布在印度海得拉巴启用一家分析服务实验室。这家符合药品生产质量管理规范(GMP)的专属设施由经过验证的实验室信息管理系统(LIMS)进行管理。它符合监管部门和客户对药品开发及市场营销所要求的最高品质标准。 GVK...
View ArticleClik here to view.
Cook Medical在新加坡启用新的配送中心
新加坡 Cook Medical位于新加坡的先进的东南亚配送中心(SADC)已于2016年11月30日正式开业。新配送中心是Cook Medical供应链迅速扩张策略的一部分，旨在满足亚太地区不断增长的产品需求。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View Article